| Product Code: ETC8264650 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market - Industry Life Cycle |
3.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market - Porter's Five Forces |
3.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.8 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.9 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of pharmacogenetics testing in psychiatry/depression among healthcare professionals and patients in Mauritius |
4.2.2 Growing prevalence of psychiatric disorders and depression in Mauritius, leading to a higher demand for personalized treatment options |
4.2.3 Government initiatives and policies supporting the integration of pharmacogenetics testing in mental healthcare practices in Mauritius |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services and technologies, potentially hindering the adoption of pharmacogenetics testing in psychiatry/depression in Mauritius |
4.3.2 Concerns regarding data privacy and ethical considerations related to genetic testing, which may impact the willingness of individuals to undergo pharmacogenetics testing |
5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Trends |
6 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Types |
6.1 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Mood Disorders, 2021- 2031F |
6.1.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Depression, 2021- 2031F |
6.1.6 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Bipolar Disorders, 2021- 2031F |
6.1.7 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Psychotic Disorders, 2021- 2031F |
6.1.8 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Eating Disorders, 2021- 2031F |
6.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.2.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Chromosomal Array-Based Tests, 2021- 2031F |
6.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Gene Type |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.3.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2C9 AND VKORC1, 2021- 2031F |
6.3.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.3.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HLA-B, 2021- 2031F |
6.3.6 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HTR2A/C, 2021- 2031F |
6.3.7 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HLA-A, 2021- 2031F |
6.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Patient Type |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Child, 2021- 2031F |
6.4.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Instruments, 2021- 2031F |
6.5.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Consumables, 2021- 2031F |
6.5.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Software & Services, 2021- 2031F |
6.6 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.6.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Dignostics Laboratories, 2021- 2031F |
6.6.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Academic And Research Institutes, 2021- 2031F |
6.6.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Third-Party Distribution, 2021- 2031F |
6.7.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F |
7 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Import-Export Trade Statistics |
7.1 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Export to Major Countries |
7.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Imports from Major Countries |
8 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Key Performance Indicators |
8.1 Rate of adoption of pharmacogenetics testing in psychiatry/depression among healthcare facilities in Mauritius |
8.2 Number of research studies and clinical trials conducted on the efficacy of pharmacogenetics testing in mental health treatment in Mauritius |
8.3 Patient satisfaction levels and reported improvements in treatment outcomes following pharmacogenetics testing in psychiatry/depression in Mauritius |
9 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market - Opportunity Assessment |
9.1 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.4 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.5 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market - Competitive Landscape |
10.1 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Pharmacogenetics Testing in Psychiatry/Depression Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here